WeVote
Log In

Bill

Bill

S 377

Prohibits health insurance carriers from obtaining pharmacy benefits manager licenses.

2026-2027 Regular Session Introduced by Vin Gopal and 1 co-sponsor

Prohibits NJ health insurers from owning or operating pharmacy benefits managers, forcing structural separation to reduce conflicts of interest in drug pricing and coverage decisions.

Introduced in the Senate, Referred to Senate Commerce Committee
0
WeVote Research Nonpartisan
Bill Summary · S 377

Legislative bill overview

S 377 prohibits health insurance carriers from obtaining or holding pharmacy benefits manager (PBM) licenses in New Jersey. This creates a structural separation between the insurance and PBM industries, preventing vertical integration where insurers directly operate PBM operations.

Why is this important

PBMs control drug formularies, negotiate with pharmacies, and process claims—giving them significant power over medication access and costs. Allowing insurers to own PBMs creates conflicts of interest where the insurer profits from both higher drug prices (as PBM owner) and lower claims (as insurer). This separation is intended to increase transparency and reduce potential price manipulation.

Potential points of contention

  • Industry consolidation concerns: Critics argue this may reduce operational efficiency and increase costs if insurers must contract with independent PBMs rather than control the process internally
  • Existing arrangements: Unclear whether this applies retroactively to current insurance-PBM partnerships, creating implementation complexity
  • Economic impact: PBM-owning insurers may face divestiture requirements or restructuring, potentially affecting their business models and consumer options in New Jersey

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.